CNS Neuroscience & Therapeutics

Papers
(The H4-Index of CNS Neuroscience & Therapeutics is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Cover Image176
Differential inflammation responses determine the variable phenotypes of epilepsy induced by GABRG2 mutations110
A rare case of encephalomyelitis caused by Candida parapsilosis104
The role of the thalamus in modular functional networks in temporal lobe epilepsy with cognitive impairment93
Supratentorial hydrocephalus with an anti‐glial fibrillary acidic protein (GFAP) antibody‐positive status: A case report74
73
Recognizing Alzheimer's disease from perspective of oligodendrocytes: Phenomena or pathogenesis?73
The interaction between intestinal microenvironment and stroke69
mGluR1/IP3/ERK signaling pathway regulates vestibular compensation in ON UBCs of the cerebellar flocculus66
Front cover65
Additional Cover63
Issue Information62
Auditory–limbic–cerebellum interactions and cognitive impairments in noise‐induced hearing loss60
Combined behavioral and EEG evidence for the 70 Hz frequency selection of short‐term spinal cord stimulation in disorders of consciousness60
Hypoxic postconditioning drives protective microglial responses and ameliorates white matter injury after ischemic stroke60
Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients57
Activation of STING signaling aggravates chronic alcohol exposure‐induced cognitive impairment by increasing neuroinflammation and mitochondrial apoptosis55
Benefit of endovascular treatment for primary versus secondary medium vessel occlusion: A multi‐center experience51
Decreased cold‐inducible RNA‐binding protein (CIRP) binding to GluRl on neuronal membranes mediates memory impairment resulting from prolonged hypobaric hypoxia exposu48
Elevated Activity in Left Homologous Music Circuits Is Inhibitory for Music Perception but Mediated by Structure–Function Coupling46
Effect of deep brain stimulation on brain network and white matter integrity in Parkinson's disease46
Therapeutic effects of exendin‐4 on spinal cord injury via restoring autophagy function and decreasing necroptosis in neuron45
Optic nerve compression associated with visual cortex functional alteration in dysthyroid optic neuropathy: A combined orbital and brain imaging study45
Alterations in metabolome and lipidome in patients with in‐stent restenosis43
Differences in survival prognosticators between children and adults with H3K27M‐mutant diffuse midline glioma42
A neuromarker for deficit syndrome in schizophrenia from a combination of structural and functional magnetic resonance imaging42
Shared genetics and causal association between plasma levels of SARSCoV‐2 entry receptor ACE2 and Alzheimer's disease41
Role of Hippocampal Glutamatergic Synaptic Alterations in Sevoflurane‐Induced Cognitive Dysfunction in Aged Mice40
Neuroimaging alterations in dementia with Lewy bodies and neuroimaging differences between dementia with Lewy bodies and Alzheimer's disease: An activation likelihood estimation meta‐analysis40
Effect of stress‐induced hyperglycemia after non‐traumatic non‐aneurysmal subarachnoid hemorrhage on clinical complications and functional outcomes39
Variants in BRWD3 associated with X‐linked partial epilepsy without intellectual disability39
Effects of Transcranial Direct Current Stimulation Targeting Dorsolateral Prefrontal Cortex and Orbitofrontal Cortex on Somatic Symptoms in Patients With Major Depressive Disorder: A Randomized, Doubl36
Advances of the MAPK pathway in the treatment of spinal cord injury36
First‐in‐Human Study of BAT4406F, an ADCC‐Enhanced Fully Humanized Anti‐CD20 Monoclonal Antibody in Patients With Neuromyelitis Optica Spectrum Disorders36
Thalamic Volumes and Functional Networks Linked With Self‐Regulation Dysfunction in Major Depressive Disorder35
The Neuroprotection of 1,2,4‐Triazole Derivative by Inhibiting Inflammation and Protecting BBB Integrity in Acute Ischemic Stroke35
0.084945917129517